SK Bioscience’s Typhoid Conjugate Vaccine Receives WHO Pre-Qualification Certification
The typhoid conjugate vaccine developed by SK Bioscience has obtained the WHO (World Health Organization) PQ (Pre-Qualification) certification, giving the green light to enter the foreign market. SK Bioscience announced on the 23rd that the typhoid conjugate vaccine “Skytyphoid Multi-Injection (project name NBP618, hereinafter referred to as Skytypoid)” jointly developed with IVI (International Vaccine Institute) […]
SK Bioscience Approved to Supply Improved Novavax COVID-19 Vaccine in Asia
Improved Novavax COVID-19 Vaccine Receives Urgent Approval from Ministry of Food and Drug Safety SK Bioscience, under the leadership of CEO Jae-yong Ahn, has received urgent approval from the Ministry of Food and Drug Safety for its improved unit cost vaccine, the Novavax COVID-19 Vaccine 2023-2024, designed to combat the omicron submutation (XBB.1.5) using synthetic […]
SK Bioscience Receives Approval for Improved Novavax COVID-19 Vaccine Against Omicron Submutation
SK Bioscience Receives Emergency Approval for Improved COVID-19 Vaccine By Kim Jung-il, Medical News Correspondent SK Bioscience announced that it has received emergency use approval from the Ministry of Food and Drug Safety for its improved unit cost vaccine, the Novavax formulation COVID-19 Vaccine 2023-2024, designed to combat the omicron submutation (XBB.1.5) using synthetic antigens […]
The Competition Heats Up in the Flu Vaccine Market Amidst COVID-19 Resurgence
Flu Vaccine Market Competition Intensifies in South Korea Government Recommends Active Flu Vaccination Amidst the Pandemic As the resurgence of COVID-19 raises concerns about a potential ‘twin pandemic’, the South Korean government has started actively promoting flu vaccination. This has sparked intensified competition among pharmaceutical and biotech companies vying for dominance in the flu vaccine […]
Compulsory Vaccination Self-Sufficiency Section: B&C Clips Joins Efforts to Develop Premium Vaccines
Joining the Compulsory Vaccination Self-Sufficiency Division: BNC Clips Aims to Develop Premium Vaccines In a recent announcement, BNC Clips, led by CEO Ji Jun-hwan, revealed its involvement in the essential vaccination self-sufficiency division of the Vaccine Commercialization Council. This council, jointly operated by the Ministry of Health and Welfare and the Vaccine Commercialization Technology Development […]
Yuhan Corporation Surpasses SK Bioscience as Third Largest Bio Stock in KOSPI with Success of Blockbuster Drug ‘Lecraza’
Yuhan Corporation Emerges as Third Largest Bio Stock in KOSPI Surpassing SK Bioscience In the third quarter, Yuhan Corporation has surpassed SK Bioscience in terms of market capitalization, securing its position as the third largest bio stock in KOSPI. The recent success of their new non-small cell lung cancer drug, ‘Lecraza,’ which showed positive results […]
Shinil Pharmaceutical Raises Supply Price of Sitagliptin XR, Diabetes Drug, Prompting Complaints from Load Companies
Shinil Pharmaceutical has announced an increase in the supply price of its ‘complex Sitagliptin XR’ diabetes drug, which has led to complaints from load companies. The price increase will be implemented for all distributions except for the first batch. The increase in price comes as the patent for Sitagliptin expires on September 1, which is […]
JW Shinyak to Resume Sales of SK Bioscience’s ‘SKYCellflu Quadrivalent’ Flu Vaccine
SK Bioscience’s flu vaccine, ‘SKYCellflu Quadrivalent’, will soon be back on the market, as announced by JW Shinyak’s CEO, Kim Yong-kwan. This follows a joint sales agreement between JW Shinyak and SK Bioscience dating back to 2016, which saw JW Shinyak take charge of sales and marketing activities for specialized medical facilities, including dermatology, urology, […]
Bio Economy 2.0 Roundtable Aims to Make Korea the Leading Biopharmaceutical Manufacturing Country
‘Bio Economy 2.0 Roundtable’ Aims to Propelling South Korea to the Forefront of Biopharmaceutical Manufacturing SEOUL – In a bid to establish itself as a global leader in biopharmaceutical manufacturing, South Korea hosted the ‘Bio Economy 2.0 Roundtable’ on the 19th. The event was attended by government officials, CEOs of major bio companies, and heads […]
SK Bioscience Participates in Pandemic Convention General Assembly Workshop as Panelist
SK Bioscience Participates in Pandemic Convention General Assembly Workshop SK Bioscience, the only private company invited to the Pandemic Convention General Assembly workshop in Geneva, Switzerland, discussed research and development capabilities for pandemics. President Ahn Jae-yong represented the company in the discussion, highlighting their strategy to develop a pandemic vaccine within 100 days through global […]
